CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants

Andrew D Redd, Alessandra Nardin, Hassen Kared, Evan M Bloch, Andrew Pekosz, Oliver Laeyendecker, Brian Abel, Michael Fehlings, Thomas C Quinn, Aaron AR Tobian
doi: https://doi.org/10.1101/2021.02.11.21251585

Article usage

Article usage: February 2021 to November 2024

AbstractFullPdf
Feb 2021179736630
Mar 2021181490604
Apr 20212243189612
May 202167932246
Jun 202188023193
Jul 202146217104
Aug 20213448988
Sep 20211881550
Oct 2021166650
Nov 20213566111
Dec 20212601678
Jan 2022155725
Feb 202298129
Mar 2022106222
Apr 202286118
May 202294522
Jun 202290077
Jul 202248269
Aug 202261011
Sep 202292413
Oct 202266215
Nov 202239113
Dec 202232215
Jan 202340314
Feb 20233854
Mar 20234724
Apr 20233329
May 20233449
Jun 20232355
Jul 20231027
Aug 2023231213
Sep 20231352
Oct 20231918
Nov 20233825
Dec 20232353
Jan 20241007
Feb 20242408
Mar 202419615
Apr 20242858
May 20241606
Jun 20242439
Jul 20242526
Aug 202434512
Sep 20242639
Oct 20241458
Nov 2024312
Back to top
Posted February 12, 2021.
Download PDF

Supplementary Material

Data/Code
Email
CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants
Andrew D Redd, Alessandra Nardin, Hassen Kared, Evan M Bloch, Andrew Pekosz, Oliver Laeyendecker, Brian Abel, Michael Fehlings, Thomas C Quinn, Aaron AR Tobian
medRxiv 2021.02.11.21251585; doi: https://doi.org/10.1101/2021.02.11.21251585
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area